Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

BACKGROUND: Recent works have suggested a possible link between interleukin (IL)-33 and B-cell biology. We aimed to study the possible association between serum IL-33 detection and response to rituximab (RTX) in rheumatoid arthritis (RA) patients in different cohorts with an accurate enzyme-linked i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sellam, Jérémie, Rivière, Elodie, Courties, Alice, Rouzaire, Paul-Olivier, Tolusso, Barbara, Vital, Edward M., Emery, Paul, Ferraciolli, Gianfranco, Soubrier, Martin, Ly, Bineta, Hendel Chavez, Houria, Taoufik, Yassine, Dougados, Maxime, Mariette, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154136/
https://www.ncbi.nlm.nih.gov/pubmed/27964756
http://dx.doi.org/10.1186/s13075-016-1190-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154136/
https://www.ncbi.nlm.nih.gov/pubmed/27964756
http://dx.doi.org/10.1186/s13075-016-1190-z

Ejemplares similares